← Eichor
Condition: Palmoplantar Pustulosis Ppp Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Palmoplantar Pustulosis Ppp

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis
Phase 4 · 1 location(s) · First Hospital of China Medical University · NCT07503652A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Phase 3 · 87 location(s) · UCB Biopharma SRL · NCT07219420A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatme
NA · 1 location(s) · Xijing Hospital · NCT07270003International Rare And Severe Psoriasis Expert Network
Phase N/A · 8 location(s) · University Hospital, Basel, Switzerland · NCT04359394
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.